Page last updated: 2024-09-04

esorubicin and Carcinoma, Non-Small Cell Lung

esorubicin has been researched along with Carcinoma, Non-Small Cell Lung in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19902 (50.00)18.7374
1990's2 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blough, RR; Johnson, CM; Kilton, LJ; Lad, TE; Rose, C; Rosen, ST; Rossof, AH; Schor, J1
Green, M; Modeas, C; Muss, HB; Norton, L; Perry, MC; Propert, KJ; Ringenberg, QS; Schilsky, RL; Weiss, RB1
Graziano, S; Green, M; Hirsh, V; Modeas, C; Perry, MC; Propert, KJ; Richards, F; Ringenberg, QS; Weiss, RB1
Abrams, J; Aisner, J; Conley, BA; Eisenberger, M; Hiponia, D; Hornedo, J; Van Echo, DA1

Trials

1 trial(s) available for esorubicin and Carcinoma, Non-Small Cell Lung

ArticleYear
Phase II trial of 4' deoxydoxorubicin (DXDX) for unresectable non-small cell bronchogenic carcinoma. An Illinois Cancer Council study.
    Investigational new drugs, 1990, Volume: 8, Issue:1

    Topics: Adult; Antibiotics, Antineoplastic; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Doxorubicin; Drug Evaluation; Humans; Lung Neoplasms; Middle Aged; Multicenter Studies as Topic

1990

Other Studies

3 other study(ies) available for esorubicin and Carcinoma, Non-Small Cell Lung

ArticleYear
Clinical cardiotoxicity of esorubicin (4'-deoxydoxorubicin,DxDx): prospective studies with serial gated heart scans and reports of selected cases. A Cancer and Leukemia Group B report.
    Investigational new drugs, 1990, Volume: 8, Issue:2

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Arrhythmias, Cardiac; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Doxorubicin; Drug Evaluation; Female; Heart Failure; Humans; Lung Neoplasms; Male; Middle Aged; Pancoast Syndrome

1990
Phase II trial of 4'-deoxydoxorubicin (DxDx) in non-small cell lung cancer: a Cancer and Leukemia Group B Trial.
    Medical and pediatric oncology, 1988, Volume: 16, Issue:1

    Topics: Carcinoma, Non-Small-Cell Lung; Doxorubicin; Drug Evaluation; Humans; Lung Neoplasms

1988
Phase II trial of 4'-deoxydoxorubicin in advanced non-small cell lung cancer.
    Cancer treatment reports, 1987, Volume: 71, Issue:9

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Doxorubicin; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged

1987